Advertisement
Screener

Amici Capital, LLC Historic Quarter Change: USA Bonds: Convertible Notes, Reduced

Amici Capital, LLC historic quarter change: USA Bonds: Convertible Notes, Reduced

In convertible notes that pay a coupon (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Amici Capital, LLC opened 5 positions, added to 1, reduced 4 and sold out of 5.

  • Q2 2016: Stock BIOMARIN PHARMACEUTICAL INC; Country of operation —; Class NOTE 1.875% 4/2; Principal before $6,304,000.
  • Q2 2016: Stock SEQUENOM INC; Country of operation —; Class NOTE 5.000%10/0; Principal before $10,000,000.
  • Q1 2016: Stock BIOMARIN PHARMACEUTICAL INC; Country of operation —; Class NOTE 1.875% 4/2; Principal before $7,804,000.
  • Q4 2015: Stock BIOMARIN PHARMACEUTICAL INC; Country of operation —; Class NOTE 1.875% 4/2; Principal before $8,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1326537), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2005-02-14.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2016BIOMARIN PHARMACEUTICAL INC
CUSIP 09061GAD3
NOTE 1.875% 4/2$6,304,000$982,000-5,322,000$25,334,000$3,721,000-$21,613,0002016-08-15
Q2 2016SEQUENOM INC
CUSIP 817337AB4
NOTE 5.000%10/0$10,000,000$6,000,000-4,000,000$7,938,000$3,683,000-$4,255,0002016-08-15
Q1 2016BIOMARIN PHARMACEUTICAL INC
CUSIP 09061GAD3
NOTE 1.875% 4/2$7,804,000$6,304,000-1,500,000$39,903,000$25,334,000-$14,569,0002016-05-16
Q4 2015BIOMARIN PHARMACEUTICAL INC
CUSIP 09061GAD3
NOTE 1.875% 4/2$8,000,000$7,804,000-196,000$40,855,000$39,903,000-$952,0002016-02-16

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet